Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA 1mg dose of Wegovy sits part-way through the titration schedule — not the starting point, not the maintenance target — and its price in the UK private market reflects that. Any legitimate price you see for semaglutide at this strength includes a prescription issued after a clinical assessment; the medicine is prescription-only, and no registered pharmacy can supply it otherwise. Private monthly costs vary by provider, dose, and what the headline figure actually covers. How UK Wegovy pricing works overall gives the broader picture, but this page focuses on what drives the cost at the 1mg mark and how to read what you're being quoted.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy is titrated gradually, the prescribing schedule starts at 0.25mg and steps up through 0.5mg, 1mg and 1.7mg before reaching the 2.4mg maintenance dose, with roughly four weeks at each level. The 1.7mg stage and the 2.4mg maintenance dose sit above this point; the 0.5mg step sits below. At 1mg, you are in the middle of a dose-escalation designed to balance tolerability with progressive effect.
In practice, UK private providers price semaglutide pens by strength, and market rates shift when Novo Nordisk adjusts its wholesale prices. Since Eli Lilly's widely-reported list-price increase for tirzepatide in September 2025, the whole GLP-1 private market has attracted closer scrutiny on cost, but semaglutide pricing follows its own supply and demand curve. The full wegovy costs breakdown covers how those variables stack up. Prices in the private sector are broadly set by the cost of goods, regulatory overheads, clinical staffing, and dispensing infrastructure, not an arbitrary markup.
What matters is that 1mg wegovy price comparisons between providers are only meaningful when you are comparing the same thing: treatment at that dose, with a valid prescription, from a pharmacy you can verify on the GPhC register.
A question our prescribers hear most weeks is some version of: "I've seen it cheaper elsewhere, why?" The honest answer is usually that cheaper quoted prices exclude one or more of the things that add real cost to a compliant service.
Common omissions in low headline prices include: the consultation fee (some providers charge this separately, billed before you know whether you're approved); a prescription fee on top of the medicine cost; delivery charges that appear at checkout; and aftercare, ongoing clinical oversight between orders. The NHS semaglutide guidance via the NHS medicines page for semaglutide makes clear this is a prescription-only medicine requiring clinical supervision, which means legitimate providers carry real staffing costs to deliver it safely.
Some providers also quote for a single pen without specifying whether that covers a full month's supply at that dose. At 1mg Wegovy, one pen delivers four weekly doses, so a monthly quote and a per-pen quote should be equivalent, but it is worth checking. The specific cost of 1mg Wegovy page addresses what a single supply period should realistically include.
nume prices treatment as a single, transparent figure, consultation, prescription, the medicine, and next-working-day tracked delivery are all covered. There are no subscriptions and no auto-renewals; every repeat order is clinically re-reviewed before dispatch. We are not the cheapest option in the market, and that is a deliberate position: the cost of a genuine clinical service, GPhC-registered pharmacy infrastructure, and next-day DPD delivery is real, and we would rather explain it than hide it behind a low headline price.
If you order before 12pm Monday to Friday and your prescription is approved, your treatment is dispatched the same day. Current treatment pricing, including what applies at each stage of the titration schedule, is on the treatment page. We do not publish per-pen prices in this copy because they can change, and because the price alone tells you less than you think.
For a broader sense of how semaglutide compares to other licensed options, the weight-loss treatments overview sets out what is licensed for weight management in the UK and how the medicines differ.
For most purchases, price is a perfectly sensible filter. Prescription medicines are different. Wegovy at any dose (including 1mg) is a Prescription-Only Medicine under UK law. The clinical assessment before prescribing exists to catch contraindications, check for drug interactions, and confirm the medicine is appropriate for you. A provider who skips or shortcuts that process does not offer a better deal; it offers a different product, and a riskier one.
The MHRA has issued repeated warnings about fake semaglutide pens circulating online, some sold through social media with no clinical assessment involved. Counterfeit pens have been found to contain other substances entirely. The MHRA Yellow Card scheme allows you to report suspected counterfeit sellers, and the GPhC register lets you confirm whether any pharmacy you are considering is registered and regulated. A price well below market norms for a licensed GLP-1 medicine is not a bargain, it is a signal worth investigating before you act. The clinical team behind how nume operates exists precisely to make the regulated route straightforward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.